...
首页> 外文期刊>Stroke Research and Treatment >Results of Surgical and Nonsurgical Treatment of Aneurysms in a Developing Country
【24h】

Results of Surgical and Nonsurgical Treatment of Aneurysms in a Developing Country

机译:发展中国家的外科手术和非手术治疗结果

获取原文
           

摘要

Background. The impact of invasive methods of treatment on results in developing countries may differ from that in developed countries.Methods. This is a prospective clinical study of consecutive patients with Subarachnoid Haemorrhage (SAH) admitted to the Ghaem Hospital, Mashhad during the period from 2005 to 2009. The initial diagnosis and investigations were carried out by neurologists. The patients were divided into two groups. One received surgical treatment whilst the other group was managed medically. The decision as to the choice of the method of treatment was made by the neurosurgeons. The initial medical treatment was standardised for all the patients. The rate of complications and mortality was compared in both medical and surgical groups.Results. 120 SAH patients (52% females) with a mean age of 50.6 ± 7 years were evaluated. The angiography revealed the presence of an aneurysm in 62 patients. 63.5% of the patients received medical treatment and 37.5% underwent aneurysmal surgery. Difference of rebleeding rate in the two therapeutic groups was not significant;X2=.014,P=.91. The effect of rebleeding on mortality was not significant;X2=2.54,P=.14. Within 62 SAH patients with cerebral aneurysm, the mortality rate in both therapeutic groups was also not significantly different;X2=.16,P=.77.Conclusion. There is no significant difference in the mortality rate between the “surgical” and non-“surgical” groups of Iranian patients with SAH. This could be due to delay in performance of surgery in Iranian neurovascular centers.
机译:背景。侵入性治疗方法对发展中国家结果的影响可能与发达国家不同。这是一项前瞻性临床研究,对2005年至2009年期间连续住院的Mashhad Ghaem医院蛛网膜下腔出血(SAH)患者进行了初步诊断和调查。将患者分为两组。一个接受手术治疗,而另一组接受药物治疗。由神经外科医生来决定治疗方法的选择。所有患者的初始药物治疗均已标准化。比较医疗组和手术组的并发症发生率和死亡率。评估了120例SAH患者(女性占52%),平均年龄为50.6±7岁。血管造影显示62例患者存在动脉瘤。 63.5%的患者接受了药物治疗,37.5%的患者接受了动脉瘤手术。两个治疗组的再出血率差异不显着; X2 = .014,P = .91。再出血对死亡率的影响不显着; X2 = 2.54,P = .14。在62例SAH脑动脉瘤患者中,两个治疗组的死亡率也无显着差异; X2 = .16,P = .77。伊朗SAH患者的“手术”和非“手术”组之间的死亡率没有显着差异。这可能是由于伊朗神经血管中心的手术延误所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号